BDBM738210 N-(3-cyanobenzyl)-2-(3-(pyridin-2-yl)-4-(quinolin-4-yl)-1H-pyrazol-1-yl)acetamide::US12297186, Example 13

SMILES N#CC1C=C(CNC(=O)Cn2cc(-c3ccnc4ccccc34)c(-c3ccccn3)n2)C=CC1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 738210   

TargetTGF-beta receptor type-1(Human)
Agomab Spain, S.L.U.

US Patent
LigandPNGBDBM738210(N-(3-cyanobenzyl)-2-(3-(pyridin-2-yl)-4-(quinolin-...)
Affinity DataIC50: 450nMAssay Description:Human TGFβl R-1 inhibition experiments were carried out in a white 384-microplate low flange (Corning 3572) with ADP-Glo kinase Assay Kit (Promega V9...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/11/2025
Entry Details
US Patent